Vlad Coric - 22 Sep 2022 Form 3 Insider Report for Biohaven Ltd. (BHVN)

Role: Chief Executive Officer, Director
Signature: /s/ George Clark, Attorney-in-Fact
Issuer symbol: BHVN
Transactions as of: 22 Sep 2022
Net transactions value: $0
Form type: 3
Filing time: 28 Sep 2022, 20:51:52 UTC
Previous filing: 07 Jan 2022
Next filing: 12 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BHVN	No Securities Owned						0	22 Sep 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 3 is being filed in connection with the Securities and Exchange Commission's declaration of effectiveness of the Registration Statement on Form 10 of Biohaven Ltd., which describes the planned distribution by Biohaven Pharmaceutical Holding Company Ltd. of all of the common shares of Biohaven Ltd. Beginning on September 23, 2022, Issuer common shares traded on a "when-issued" basis on the New York Stock Exchange under the symbol "BHVN WI" and under "Biohaven Ltd." When-issued trading of SpinCo common shares will continue until the distribution occurs. SpinCo common shares are expected to begin "regular-way" trading on the NYSE under the symbol "BHVN" on the first trading day following the distribution date.